DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mesna (Mesna) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mesna where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mesna side effects in male

Reported by a physician from Poland on 2012-06-22

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Etoposide
    Dosage: 96mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Mesna
    Dosage: 128mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Cytosar-U
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-17

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16

Ifosfamide
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Other drugs received by patient: Zokzid; Metronidazole; Albuminar-20; Sodium Chloride 0.9%; Diflucan; Meropenem; 5% Glucose; Furosemide



Possible Mesna side effects in male

Reported by a physician from Poland on 2012-06-19

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Etoposide
    Dosage: 96mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Cytosar-U
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-17

Ifosfamide
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Mesna
    Dosage: 128mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16

Other drugs received by patient: Furosemide; Albuminar-20; Zokzid; Diflucan; 5% Glucose; Meropenem; Metronidazole; Sodium Chloride 0.9%



Possible Mesna side effects in male

Reported by a physician from Poland on 2012-06-15

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Pneumonia, Blood PH Decreased, Haemoglobin Decreased, Haematocrit Decreased, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Circulatory Collapse, Platelet Count Decreased, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Etoposide
    Dosage: 96mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Cytosar-U
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-17

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16

Mesna
    Dosage: 128mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Ifosfamide
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Other drugs received by patient: Diflucan; Albuminar-20; Metronidazole; Zokzid; Meropenem; 5% Glucose; Furosemide; Sodium Chloride 0.9%



Possible Mesna side effects in male

Reported by a physician from Poland on 2012-06-14

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Etoposide
    Dosage: 96mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Mesna
    Dosage: 128mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16

Cytosar-U
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-17

Other drugs received by patient: Metronidazole; Meropenem; Furosemide; Zokzid; Diflucan; Sodium Chloride 0.9%; Albuminar-20; 5% Glucose



Possible Mesna side effects in male

Reported by a physician from Poland on 2012-05-31

Patient: male, weighing 62.0 kg (136.4 pounds)

Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Etoposide
    Dosage: 96mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Cytosar-U
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-17

Mesna
    Dosage: 128mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16

Ifosfamide
    Dosage: 1600mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-05-16
    End date: 2012-05-20

Other drugs received by patient: Metronidazole; Zokzid; 5% Glucose; Furosemide; Diflucan; Sodium Chloride 0.9%; Meropenem; Albuminar-20



Possible Mesna side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02

Patient: 31 year old male

Reactions: Pneumonia, Syncope, Fatigue, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituxan
    Dosage: 788 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Doxorubicin HCL
    Dosage: 103 mg, unk
    Indication: non-Hodgkin's Lymphoma

Neulasta
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 6.3 g, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 618 mg, unk
    Indication: non-Hodgkin's Lymphoma

Leucovorin Sodium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Dosage: 1236 mg, unk
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Ciprofloxacin; Valtrex; Medrol; Fluconazole; Voriconazole; Protonix



Possible Mesna side effects in male

Reported by a physician from United States on 2012-01-30

Patient: male

Reactions: Pneumonia, Fatigue, Syncope, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituximab
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Neulasta
    Indication: Product Used FOR Unknown Indication

Leucovorin Calcium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Ciprofloxacin; Voriconazole; Fluconazole; Protonix; Valtrex; Medrol



Possible Mesna side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-24

Patient: 31 year old male

Reactions: Fatigue, Syncope, Pneumonia, Hypotension, Anaemia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mesna
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Methotrexate
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Leucovorin Calcium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Vincristine Sulfate
    Indication: non-Hodgkin's Lymphoma

Pegfilgrastim
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Fluconazole; Voriconazole; Ciprofloxacin; Medrol; Pantoprazole; Valtrex



Possible Mesna side effects in male

Reported by a individual with unspecified qualification from United States on 2011-12-19

Patient: male

Reactions: Fatigue, Syncope, Pneumonia, Hypotension, Anaemia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma

Leucovorin Calcium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Mabthera

Cytarabine
    Dosage: 6.3 g, x4
    Indication: non-Hodgkin's Lymphoma

Leucovorin Calcium
    Dosage: 15 mg, q6h
    Administration route: Oral

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Mesna
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 1680 mg, unk

Mabthera
    Dosage: 788 mg, unknown
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Medrol; Fluconazole; Protonix; Ciprofloxacin; Valtrex



Possible Mesna side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-19

Patient: 31 year old male

Reactions: Pneumonia, Fatigue, Syncope, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 103 mg, unk
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 618 mg, unk
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Leucovorin Sodium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Dosage: 1236 mg, unk
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: 788 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 6.3 g, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Protonix; Medrol; Voriconazole; Valtrex; Ciprofloxacin; Fluconazole



Possible Mesna side effects in male

Reported by a physician from United States on 2011-10-26

Patient: male, weighing 65.8 kg (144.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Vomiting, Nausea, Hypotension, Pyrexia, Headache, Hypokalaemia, Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: 24.775 g

Mesna
    Dosage: 24.75 g

Etoposide
    Dosage: 875 mg

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017